Sign in

CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
822082553
Phone
(781) 222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
  1. 4 Insider Changes in Ownership
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. SC 13G/A Stake Amended Statement of Ownership
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 4 Insider Changes in Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 8-K Event Shareholder vote results
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. EFFECT Other Notice of Effectiveness
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. UPLOAD Other SEC-generated Letter

Page 9 of 34 · 662 filings